[Federal Register Volume 85, Number 196 (Thursday, October 8, 2020)]
[Notices]
[Pages 63591-63592]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22226]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[NRC-2020-0221]
Information Collection: NRC Form 483, ``Registration
Certificate--In Vitro Testing With Byproduct Material Under General
License''
AGENCY: Nuclear Regulatory Commission.
ACTION: Renewal of existing information collection; request for
comments.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) invites public
comment on the renewal of Office of Management and Budget (OMB)
approval for an existing collection of information. The information
collection is entitled, NRC Form 483, ``Registration Certificate--In
Vitro Testing with Byproduct Material Under General License.''
DATES: Submit comments by December 7, 2020. Comments received after
this date will be considered if it is practical to do so, but the
Commission is able to ensure consideration only for comments received
on or before this date.
ADDRESSES: You may submit comments by any of the following methods:
Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2020-0221. For
technical questions, contact the individual listed in the FOR FURTHER
INFORMATION CONTACT section of this document.
Mail comments to: David Cullison, Office of the Chief
Information Officer, Mail Stop: T-6 A10M, U.S. Nuclear Regulatory
Commission, Washington, DC 20555-0001.
For additional direction on obtaining information and submitting
comments, see ``Obtaining Information and Submitting Comments'' in the
SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: David Cullison, Office of the Chief
Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001; telephone: 301-415-2084; email:
[email protected].
SUPPLEMENTARY INFORMATION:
I. Obtaining Information and Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC-2020-0221 when contacting the NRC
about the availability of information for this action. You may obtain
publicly available information related to this action by any of the
following methods:
Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2020-0221. A copy of
the collection of information and related instructions may be obtained
without charge by accessing Docket ID NRC-2020-0221 on this website.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may obtain publicly available documents online in the
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS,
please contact the NRC's Public Document Room (PDR) reference staff at
1-800-397-4209, 301-415-4737, or by email to [email protected]. A
copy of the collection of information and related instructions may be
obtained without charge by accessing ADAMS Accession No. ML20205L413.
The supporting statement is available in ADAMS under Accession No.
ML20205L506.
NRC's Clearance Officer: A copy of the collection of
information and related instructions may be obtained without charge by
contacting NRC's Clearance Officer, David Cullison, Office of the Chief
Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC
20555-0001; telephone: 301-415-2084; email:
[email protected].
B. Submitting Comments
Please include Docket ID NRC-2020-0221 in the subject line of your
comment submission, in order to ensure that the NRC is able to make
your comment submission available to the public in this docket.
The NRC cautions you not to include identifying or contact
information in comment submissions that you do not want to be publicly
disclosed in your comment submission. The NRC will post all comment
submissions at https://www.regulations.gov as well as enter the comment
submissions into ADAMS, and the NRC does not routinely edit comment
submissions to remove identifying or contact information.
If you are requesting or aggregating comments from other persons
for submission to the NRC, then you should inform those persons not to
include identifying or contact information that they do not want to be
publicly disclosed in their comment submission. Your request should
state that the NRC does not routinely edit comment submissions to
remove such information before making the comment submissions available
to the public or entering the comment into ADAMS.
II. Background
In accordance with the Paperwork Reduction Act of 1995 (44 U.S.C.
Chapter 35), the NRC is requesting public comment on its intention to
request the OMB's approval for the information collection summarized
below.
[[Page 63592]]
1. The title of the information collection: NRC Form 483,
``Registration Certificate--In Vitro Testing with Byproduct Material
Under General License.''
2. OMB approval number: 3150-0038.
3. Type of submission: Extension.
4. The form number, if applicable: NRC Form 483.
5. How often the collection is required or requested: There is a
one-time submittal of information to receive a validated copy of the
NRC Form 483 with an assigned registration number. In addition, any
changes in the information reported on the NRC Form 483 must be
reported in writing to the NRC within 30 days after the effective date
of the change.
6. Who will be required or asked to respond: Any physician,
veterinarian in the practice of veterinary medicine, clinical
laboratory, or hospital which desires a general license to receive,
acquire, possess, transfer, or use specified units of byproduct
material in certain in vitro clinical or laboratory tests.
7. The estimated number of annual responses: 6 responses.
8. The estimated number of annual respondents: 6 respondents.
9. The estimated number of hours needed annually to comply with the
information collection requirement or request: 1.12 hours.
10. Abstract: Section 31.11 of Title 10 of the Code of Federal
Regulations (10 CFR), established a general license authorizing any
physician, clinical laboratory, veterinarian in the practice of
veterinary medicine, or hospital to possess certain small quantities of
byproduct material for in vitro clinical or laboratory tests not
involving the internal or external administration of the byproduct
material or the radiation therefrom to human beings or animals.
Possession of byproduct material under 10 CFR 31.11 is not authorized
until the physician, clinical laboratory, veterinarian in the practice
of veterinary medicine, or hospital has filed the NRC Form 483 and
received from the Commission a validated copy of the NRC Form 483 with
a registration number. The licensee can use the validated copy of the
NRC Form 483 to obtain byproduct material from a specifically licensed
supplier. The NRC incorporates this information into a database which
is used to verify that a general licensee is authorized to receive the
byproduct material.
III. Specific Requests for Comments
The NRC is seeking comments that address the following questions:
1. Is the proposed collection of information necessary for the NRC
to properly perform its functions? Does the information have practical
utility?
2. Is the estimate of the burden of the information collection
accurate?
3. Is there a way to enhance the quality, utility, and clarity of
the information to be collected?
4. How can the burden of the information collection on respondents
be minimized, including the use of automated collection techniques or
other forms of information technology?
Dated: October 2, 2020.
For the Nuclear Regulatory Commission.
David C. Cullison,
NRC Clearance Officer, Office of the Chief Information Officer.
[FR Doc. 2020-22226 Filed 10-7-20; 8:45 am]
BILLING CODE 7590-01-P